Lowered valproate doses during pregnancy may curb birth defect risks

Prenatal exposure to valproate was linked to increased odds of babies developing spina bifida and hypospadias, but researchers found that lowering the dose of the medication in the first trimester could control women's epileptic seizures without raising their child's risk of having the defects. The findings appear in the journal American Academy of Neurology.

View Full Article in:

Herald Sun (Melbourne, Australia) (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY